Literature DB >> 6373938

Detection of intracytoplasmic antigens by flow cytometry.

R W Schroff, C D Bucana, R A Klein, M M Farrell, A C Morgan.   

Abstract

A new technique is described for the detection of intracellular antigens by immunofluorescence and flow cytometry. The technique utilizes lysolecithin (lysophosphatidylcholine), a naturally occurring phospholipid, to permeabilize cell membranes and allow antibodies to reach intracellular antigens. The technique is rapid and sensitive, and retains sufficient integrity of the cells being treated to enable differentiation of cell types on the basis of light scatter (e.g., lymphocytes from monocytes). Permeabilization of cells following lysolecithin was assessed using standard techniques including trypan blue exclusion, propidium iodide staining, and hydrolysis of fluorescein diacetate. Lysolecithin treatment was accompanied by only minimal increases in non-specific background fluorescence, and no increase in autofluorescence. Our studies have demonstrated that lysolecithin treatment of human mononuclear cell populations permits flow cytometric analysis of cytoskeletal structures, including intermediate filaments, as well as cytoplasmic immunoglobulin. Studies currently in progress in our laboratory have demonstrated broad intracellular reactivity with some monoclonal antibodies identifying leukocyte differentiation and tumor-associated antigens. These findings contrast with the more restricted expression of these antigens on the cell surface and demonstrate not only the value of the lysolecithin technique but also the importance of the study of intracellular antigens in our overall understanding of the specificity, distribution, synthesis, and function of cellular antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373938     DOI: 10.1016/0022-1759(84)90182-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  B-cell antigens within normal and activated human T cells.

Authors:  G P Sandilands; M Perry; M Wootton; J Hair; I A More
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

2.  Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies.

Authors:  M P Link; S J Stewart; R A Warnke; R Levy
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Expression of T3 and T11 determinants on human peripheral lymphocytes as analysed by the indirect antiglobulin rosetting reaction (IARR) and indirect immunofluorescence.

Authors:  D G Haegert
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

4.  Demonstration of cytoplasmic CD32 (Fc gamma RII) within human lymphocytes following microwave treatment.

Authors:  G P Sandilands; E R Burnett; S A MacPherson; I Downie; I A More; R N MacSween
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

5.  Occult expression of CD32 (Fc gamma RII) in normal human peripheral blood mononuclear cells.

Authors:  G P Sandilands; A P McLaren; D Howie; R N MacSween
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

6.  Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function.

Authors:  Norris I Hollie; James G Cash; M Abdul Matlib; Matthew Wortman; Joshua E Basford; William Abplanalp; David Y Hui
Journal:  Biochim Biophys Acta       Date:  2013-12-05

7.  Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry.

Authors:  N Farahat; D van der Plas; M Praxedes; R Morilla; E Matutes; D Catovsky
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

8.  Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells.

Authors:  R A Baan; O B Zaalberg; A M Fichtinger-Schepman; M A Muysken-Schoen; M J Lansbergen; P H Lohman
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.